Diagnostic value of CD138 and GATA3 in benign prostatic hyperplasia and prostate cancer. [PDF]
Hu Y+5 more
europepmc +1 more source
Prostatitis syndromes and benign prostatic hyperplasia
Steven R. Potter, Alan W. Partin
openalex +1 more source
The evolving role of positron emission tomography in precision prostate cancer biopsy
Prostate biopsy plays a pivotal role in the detection and characterization of prostate cancer. PSMA PET‐targeted biopsy represents a significant advancement in prostate cancer diagnostics, offering higher sensitivity, specificity and accuracy in detecting clinically significant lesions compared to traditional methods. PSMA PET, when combined with mpMRI,
Alessio Imperiale+11 more
wiley +1 more source
The Utility of Tranexamic Acid in Endoscopic Surgeries for Benign Prostatic Hyperplasia. [PDF]
Siron N+3 more
europepmc +1 more source
Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein-3 in Benign Prostatic Hyperplasia and Prostate Cancer [PDF]
Javad Khosravi
openalex +2 more sources
To Rezūm or Not to Rezūm: A Narrative Review of Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia. [PDF]
Kaltsas A+9 more
europepmc +1 more source
Is Canine Prostate-Specific Esterase a Reliable Marker for Benign Prostatic Hyperplasia Progression in Dogs? [PDF]
Posastiuc FP+6 more
europepmc +1 more source
A deep learning derived prostate zonal volume‐based biomarker from T2‐weighted MRI to distinguish between prostate cancer and benign prostatic hyperplasia [PDF]
Abstract Background Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) share overlapping characteristics on magnetic resonance imaging (MRI), confounding the diagnosis and detection of PCa. There is thus a clinical need to accurately differentiate BPH‐Only from BPH‐PCa to prevent overdiagnosis and unnecessary biopsies.
Zhang Z+7 more
europepmc +2 more sources